Using Model-Based "Learn and Confirm" to Reveal the Pharmacokinetics-Pharmacodynamics Relationship of Pembrolizumab in the KEYNOTE-001 Trial. [electronic resource]
Producer: 20171016Description: 21-28 p. digitalISSN:- 2163-8306
- Antibodies, Monoclonal, Humanized -- pharmacokinetics
- Antineoplastic Agents -- blood
- Clinical Trials, Phase I as Topic -- statistics & numerical data
- Data Interpretation, Statistical
- Follow-Up Studies
- Humans
- Interleukin-2 -- antagonists & inhibitors
- Internationality
- Models, Biological
- Multicenter Studies as Topic -- statistics & numerical data
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.